NeuronFeed Submit a startup
Startups/ AI Healthcare/ Chai Discovery

Chai Discovery

Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.

Visit website
NeuronScore 29/100
Total Raised $130M
Pricing Enterprise
Stage Series B
Team
AI HealthcareDrug Discovery #Enterprise#SaaS
About Chai Discovery

Chai Discovery leverages artificial intelligence to engineer novel molecules, focusing on de novo antibody design. Their platform, Chai-2, aims to move beyond simple binding to create real therapeutic antibodies with atomic precision. This technology addresses challenging targets in drug discovery.

NeuronScore Signal quality across funding, news, traction & verification
29 /100
Tracked
Funding momentum
17/30
Active deals
0/10
News
1/12
Traffic
0/8
Verified
11/20
Freshness
0/10
Agent-Ready Score 10/100 · checked May 3, 2026
MCP
Public API
Webhooks
OAuth2
SDK · TS
SDK · Py
Alternatives 6 similar All →
FAQ
How much funding has Chai Discovery raised?
Chai Discovery has raised $130M across 1 rounds — most recently a Series B.
How much does Chai Discovery cost?
Chai Discovery pricing: Enterprise · Contact sales.
Discussion

Sign in to join the discussion.

Sign in →

No comments yet — be the first.

Contextual paths to related AI startups, deals and rankings.